A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple Myeloma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a Phase I/II, single-arm, open-label, multicenter clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM). The study aims to evaluate the safety, tolerability, efficacy, cellular kinetics, and immunogenicity of CT0596.
Epistemonikos ID: 3bae2153bddac0729eb1a59221430650a1b92a71
First added on: Aug 12, 2026